FDA Warning Letter — Prime Vitality Inc.

Case 695156 — FEI 3032711659

The FDA took a Warning Letter action against Prime Vitality Inc. on Dec 10, 2024 (Santa Barbara, CA). The action was issued by CDER and concerns drugs products.

Action Details

Facility
Prime Vitality Inc.
Date
Dec 10, 2024
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Santa Barbara, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.